Reports
Reports
The global pruritus drugs market is expected to grow at a CAGR of 5.40% in the forecast period of 2023-2028 to reach USD 4.45 billion by 2028.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The industry is being driven by the expansion of nanoparticle-enabled transdermal drug delivery systems. North America is anticipated to hold the largest share in the market during the forecast period owing to the increasing prevalence of hematologic diseases.
Pruritus is a non-fatal condition caused due to the use of immunotherapy - the immune responses to toxins released from cancerous cells. The rising adoption of immunotherapy can increase the risk of pruritus, hence, leading to an increased demand for pruritus drugs. The major application areas for the product include hematologic pruritus, oncological pruritus, renal pruritus, endocrine pruritus, and cholestatic pruritus.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The EMR report looks into the regional pruritus drugs markets like North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The global pruritus drugs market is boosted by the increasing adoption of immunotherapy and the advancement in nanoparticle-enabled transdermal drug delivery systems. The hematologic pruritus segment accounted for the largest industry share in 2020, however, the oncological pruritus segment is expected to lead the industry during the forecast period due to factors such as increasing prevalence of cancer and the growth in the study of oncology. North America is anticipated to account for the largest share in the market as a result of rising cancer incidences, growth in the percentage of the older population, and increased market penetration of pharmaceutical suppliers.
The report presents a detailed analysis of the following key players in the global pruritus drugs market, looking into their capacity, competitive landscape, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter’s five forces.
REPORT FEATURES | DETAILS |
---|---|
Base Year | 2022 |
Historical Period | 2018-2022 |
Forecast Period | 2023-2028 |
Scope of the Report | Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Application, Region |
Breakup by Application | Hematologic pruritus, Oncological pruritus, Renal pruritus, Endocrine pruritus, Cholestatic pruritus |
Breakup by Region | North America, Europe, Asia Pacific, Latin America, Middle East and Africa |
Market Dynamics | SWOT, Porter's Five Forces, Key Indicators for Price and Demand |
Competitive Landscape | Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications |
Companies Covered | Johnson & Johnson Consumer Inc., Pfizer Inc., AbbVie Inc., Astellas Pharma Inc., Others |
Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Opportunities and Challenges in the Market
8 Global Pruritus Drugs Market Analysis
8.1 Key Industry Highlights
8.2 Global Pruritus Drugs Historical Market (2018-2022)
8.3 Global Pruritus Drugs Market Forecast (2023-2028)
8.4 Global Pruritus Drugs Market by Application
8.4.1 Hematologic Pruritus
8.4.1.1 Market Share
8.4.1.2 Historical Trend (2018-2022)
8.4.1.3 Forecast Trend (2023-2028)
8.4.2 Oncological Pruritus
8.4.2.1 Market Share
8.4.2.2 Historical Trend (2018-2022)
8.4.2.3 Forecast Trend (2023-2028)
8.4.3 Renal Pruritus
8.4.3.1 Market Share
8.4.3.2 Historical Trend (2018-2022)
8.4.3.3 Forecast Trend (2023-2028)
8.4.4 Endocrine Pruritus
8.4.4.1 Market Share
8.4.4.2 Historical Trend (2018-2022)
8.4.4.3 Forecast Trend (2023-2028)
8.4.5 Cholestatic Pruritus
8.4.5.1 Market Share
8.4.5.2 Historical Trend (2018-2022)
8.4.5.3 Forecast Trend (2023-2028)
8.5 Global Pruritus Drugs Market by Region
8.5.2 North America
8.5.1.1 Market Share
8.5.1.2 Historical Trend (2018-2022)
8.5.1.3 Forecast Trend (2023-2028)
8.5.2 Europe
8.5.2.1 Market Share
8.5.2.2 Historical Trend (2018-2022)
8.5.2.3 Forecast Trend (2023-2028)
8.5.3 Asia Pacific
8.5.3.1 Market Share
8.5.3.2 Historical Trend (2018-2022)
8.5.3.3 Forecast Trend (2023-2028)
8.5.4 Latin America
8.5.4.1 Market Share
8.5.4.2 Historical Trend (2018-2022)
8.5.4.3 Forecast Trend (2023-2028)
8.5.5 Middle East and Africa
8.5.5.1 Market Share
8.5.5.2 Historical Trend (2018-2022)
8.5.5.3 Forecast Trend (2023-2028)
9 North America Pruritus Drugs Market Analysis
9.1 United States of America
9.1.1 Market Share
9.1.2 Historical Trend (2018-2022)
9.1.3 Forecast Trend (2023-2028)
9.2 Canada
9.2.1 Market Share
9.2.2 Historical Trend (2018-2022)
9.2.3 Forecast Trend (2023-2028)
10 Europe Pruritus Drugs Market Analysis
10.1 United Kingdom
10.1.1 Market Share
10.1.2 Historical Trend (2018-2022)
10.1.3 Forecast Trend (2023-2028)
10.2 Germany
10.2.1 Market Share
10.2.2 Historical Trend (2018-2022)
10.2.3 Forecast Trend (2023-2028)
10.3 France
10.3.1 Market Share
10.3.2 Historical Trend (2018-2022)
10.3.3 Forecast Trend (2023-2028)
10.4 Italy
10.4.1 Market Share
10.4.2 Historical Trend (2018-2022)
10.4.3 Forecast Trend (2023-2028)
10.5 Others
11 Asia Pacific Pruritus Drugs Market Analysis
11.1 China
11.1.1 Market Share
11.1.2 Historical Trend (2018-2022)
11.1.3 Forecast Trend (2023-2028)
11.2 Japan
11.2.1 Market Share
11.2.2 Historical Trend (2018-2022)
11.2.3 Forecast Trend (2023-2028)
11.3 India
11.3.1 Market Share
11.3.2 Historical Trend (2018-2022)
11.3.3 Forecast Trend (2023-2028)
11.4 ASEAN
11.4.1 Market Share
11.4.2 Historical Trend (2018-2022)
11.4.3 Forecast Trend (2023-2028)
11.5 Australia
11.5.1 Market Share
11.5.2 Historical Trend (2018-2022)
11.5.3 Forecast Trend (2023-2028)
11.6 Others
12 Latin America Pruritus Drugs Market Analysis
12.1 Brazil
12.1.1 Market Share
12.1.2 Historical Trend (2018-2022)
12.1.3 Forecast Trend (2023-2028)
12.2 Argentina
12.2.1 Market Share
12.2.2 Historical Trend (2018-2022)
12.2.3 Forecast Trend (2023-2028)
12.3 Mexico
12.3.1 Market Share
12.3.2 Historical Trend (2018-2022)
12.3.3 Forecast Trend (2023-2028)
12.4 Others
13 Middle East and Africa Pruritus Drugs Market Analysis
13.1 Saudi Arabia
13.1.1 Market Share
13.1.2 Historical Trend (2018-2022)
13.1.3 Forecast Trend (2023-2028)
13.2 United Arab Emirates
13.2.1 Market Share
13.2.2 Historical Trend (2018-2022)
13.2.3 Forecast Trend (2023-2028)
13.3 Nigeria
13.3.1 Market Share
13.3.2 Historical Trend (2018-2022)
13.3.3 Forecast Trend (2023-2028)
13.4 South Africa
13.4.1 Market Share
13.4.2 Historical Trend (2018-2022)
13.4.3 Forecast Trend (2023-2028)
13.5 Others
14 Market Dynamics
14.1 SWOT Analysis
14.1.1 Strengths
14.1.2 Weaknesses
14.1.3 Opportunities
14.1.4 Threats
14.2 Porter’s Five Forces Analysis
14.2.1 Supplier’s Power
14.2.2 Buyer’s Power
14.2.3 Threat of New Entrants
14.2.4 Degree of Rivalry
14.2.5 Threat of Substitutes
14.3 Key Indicators for Demand
14.4 Key Indicators for Price
15 Value Chain Analysis
16 Competitive Landscape
16.1 Market Structure
16.2 Company Profiles
16.2.1 Johnson & Johnson Consumer Inc.
16.2.1.1 Company Overview
16.2.1.2 Product Portfolio
16.2.1.3 Demographic Reach and Achievements
16.2.1.4 Certifications
16.2.2 Pfizer Inc.
16.2.2.1 Company Overview
16.2.2.2 Product Portfolio
16.2.2.3 Demographic Reach and Achievements
16.2.2.4 Certifications
16.2.3 AbbVie Inc.
16.2.3.1 Company Overview
16.2.3.2 Product Portfolio
16.2.3.3 Demographic Reach and Achievements
16.2.3.4 Certifications
16.2.4 Astellas Pharma Inc.
16.2.4.1 Company Overview
16.2.4.2 Product Portfolio
16.2.4.3 Demographic Reach and Achievements
16.2.4.4 Certifications
16.2.5 Others
17 Key Trends and Developments in the Market
List of Key Figures and Tables
1. Global Pruritus Drugs Market: Key Industry Highlights, 2018 and 2028
2. Global Pruritus Drugs Historical Market: Breakup by Application (USD Million), 2018-2022
3. Global Pruritus Drugs Market Forecast: Breakup by Application (USD Million), 2023-2028
4. Global Pruritus Drugs Historical Market: Breakup by Region (USD Million), 2018-2022
5. Global Pruritus Drugs Market Forecast: Breakup by Region (USD Million), 2023-2028
6. North America Pruritus Drugs Historical Market: Breakup by Country (USD Million), 2018-2022
7. North America Pruritus Drugs Market Forecast: Breakup by Country (USD Million), 2023-2028
8. Europe Pruritus Drugs Historical Market: Breakup by Country (USD Million), 2018-2022
9. Europe Pruritus Drugs Market Forecast: Breakup by Country (USD Million), 2023-2028
10. Asia Pacific Pruritus Drugs Historical Market: Breakup by Country (USD Million), 2018-2022
11. Asia Pacific Pruritus Drugs Market Forecast: Breakup by Country (USD Million), 2023-2028
12. Latin America Pruritus Drugs Historical Market: Breakup by Country (USD Million), 2018-2022
13. Latin America Pruritus Drugs Market Forecast: Breakup by Country (USD Million), 2023-2028
14. Middle East and Africa Pruritus Drugs Historical Market: Breakup by Country (USD Million), 2018-2022
15. Middle East and Africa Pruritus Drugs Market Forecast: Breakup by Country (USD Million), 2023-2028
16. Global Pruritus Drugs Market Structure
The market is projected to grow at a CAGR of 5.40% between 2023 and 2028.
The market is estimated to witness a healthy growth in the forecast period of 2023-2028 to reach USD 4.45 billion by 2028.
The major industry drivers in the market are rising urbanisation and industrialisation, expansion of nanoparticle-enabled transdermal drug delivery systems, and increasing prevalence of hematologic diseases.
The key trends in the market are increasing adoption of immunotherapy and advancements in technology.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific, with North America accounting for the largest share in the market.
Hematologic pruritus is the dominant application segment in the industry.
The major players in the industry are Johnson & Johnson Consumer Inc., Pfizer Inc., AbbVie Inc., and Astellas Pharma Inc., among others.
The global pruritus drugs market is driven by the expansion of nanoparticle-enabled transdermal drug delivery systems and increasing prevalence of hematologic diseases. Aided by increasing adoption of immunotherapy and advancements in technology, the market is expected to witness a further growth in the forecast period of 2023-2028, growing at a CAGR of 5.40%.
EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on its applications, the pruritus drugs industry can be segmented into hematologic pruritus, oncological pruritus, renal pruritus, endocrine pruritus, and cholestatic pruritus, with hematologic pruritus accounting for the largest market share. The major regional markets for pruritus drugs are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa, with North America accounting for the largest share of the market. The key players in the above market include Johnson & Johnson Consumer Inc., Pfizer Inc., AbbVie Inc., and Astellas Pharma Inc., among others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Mini Report
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.